Agoracom Blog Home

Archive for the ‘AGORACOM Via Satellite’ Category

280,000 Ounces of Gold, Major Critical Minerals & Near $5.5B in M&A: Renforth’s Moment Is Here

Posted by Brittany McNabb at 12:48 PM on Thursday, April 3rd, 2025

Renforth Resources: Positioned for Gold and Critical Mineral Success in Quebec

In a compelling new interview with AGORACOM, Renforth Resources Inc. (CSE: RFR | OTCQB: RFHRF | FSE: 9RR) CEO Nicole Brewster laid out a clear and convincing case for why this Canadian junior exploration company is exceptionally well-positioned amid record gold prices and rising global demand for critical minerals. With flagship assets in Quebec’s world-renowned Abitibi mining district, Renforth is advancing both its 100%-owned Parbec Gold Deposit and the massive Malartic Metals Package — a combined landholding that sits in one of the richest and most active mining corridors in North America.

Strategic Location Beside Mining Giants

Renforth’s Parbec Gold Project is situated directly adjacent to Agnico Eagle’s Canadian Malartic Mine, the country’s largest open-pit gold mine. The deposit already contains 280,000 ounces of gold (101,000 oz indicated, 177,000 oz inferred), with a new NI 43-101 resource estimate expected soon. This update will include 15,000 metres of additional drilling and could significantly increase the gold resource, especially with current gold prices near C$4,500/oz.

The Parbec project benefits from exceptional infrastructure: direct road access, two hydroelectric lines crossing the property, nearby toll milling facilities, and close proximity to the Glencore-owned Horn Smelter. As Brewster puts it, “It can’t get cheaper than this — the economics of development in this region are simply unbeatable.”

Malartic Metals Package: A Critical Mineral Powerhouse

Located just north of Parbec, the 300 km² Malartic Metals Package hosts the emerging 20-kilometre-long Victoria nickel-sulphide polymetallic structure. Recent metallurgical results show that the mineralization — which includes nickel, zinc, copper, cobalt, and silver — is hosted in conventional sulphide minerals, indicating potential for standard, cost-effective processing.

Initial mineralogical analysis and TOMRA sorting tests demonstrate strong early signs of recoverability and grade optimization. Brewster also confirmed that Renforth is working with SGS to determine whether its current drilling supports a maiden resource — an important step toward unlocking value in this new discovery.

In the Midst of $5.6 Billion in M&A

Renforth is surrounded by major mining players. Agnico Eagle has spent billions acquiring and consolidating deposits across the Abitibi in recent years, including the Yamana and O3 Mining deals. Parbec sits right in the middle of this activity, offering both strategic value and expansion potential to any nearby operator looking to sustain mill throughput or grow their regional footprint.

“This is a proven gold deposit, sitting beside a mine that’s going underground and needs more ore. The strategic value is obvious,” Brewster stated.

Quebec Advantage: Cost, Policy, and Market Access

Renforth’s position in Quebec provides significant advantages beyond geology. The province is routinely ranked as a top-tier mining jurisdiction globally, and the Quebec government recently introduced new stimulus programs specifically aimed at accelerating critical mineral exploration. With access to hydroelectric power, deepwater ports, rail lines, and North America’s battery manufacturing corridor, Renforth’s assets are ideally situated to capitalize on emerging resource trends.

Conclusion: Value Waiting to Be Realized

Despite world-class assets, infrastructure, and jurisdictional advantages, Brewster noted that capital has been hard to come by for juniors — and that Renforth has instead prioritized drilling and science over promotional spending. “We’ve outlined real metals in the ground that aren’t going anywhere. What we’re building is real,” she said.

With a new gold resource estimate imminent, growing strategic relevance in the critical minerals space, and near-term catalysts ahead, Renforth Resources appears to be an underappreciated player in a district that continues to deliver major value.

For those seeking exposure to gold and critical minerals in one of the most mining-friendly regions in the world, Renforth may be one to watch.

Watch the full interview here: 

Canadian Biotech Quantum BioPharma Nears a Landmark Multiple Sclerosis Breakthrough

Posted by Brittany McNabb at 9:54 AM on Thursday, March 27th, 2025

New Approach Could Redefine How Multiple Sclerosis Is Treated Worldwide

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) may be on the verge of redefining treatment for multiple sclerosis (MS), a chronic neurological disorder affecting nearly 3 million people worldwide. In a compelling interview on the AGORACOM, Dr. Andrzej Chruscinski, Vice-President of Scientific and Clinical Affairs at Quantum BioPharma, detailed the company’s successful completion of its Phase 1 clinical trial for Lucid-MS, a first-in-class neuroprotective drug targeting demyelination—the core driver of MS progression.

Unlike existing treatments, which primarily focus on managing the immune system and controlling inflammation, Lucid-MS takes aim at protecting and potentially repairing the myelin sheath—the protective layer around nerve cells that degenerates in MS patients. “We’re excited about the potential of Lucid-MS to protect myelin in MS patients as it represents a new direction in the treatment of this disease,” said Quantum BioPharma CEO Zeeshan Saeed.

A Novel Solution to a Persistent Problem

Most MS therapies today only address the inflammatory aspect of the disease, leaving the underlying neurodegeneration largely unaddressed. Lucid-MS changes that narrative.

  • The drug works by preventing the unraveling of the myelin sheath, a process triggered by a chemical modification known as citrullination.

  • Developed over a decade by Dr. Lakshmi Kotra and Dr. Mario Moscarello at the University of Toronto, Lucid-MS targets this key process, aiming to halt disease progression and protect nerve communication.

  • The approach has already shown success in preclinical animal models.

“Think of the myelin sheath like insulation around electrical wiring. When that’s compromised, signals can’t transmit properly,” explained Dr. Chruscinski. “Our drug preserves that insulation, maintaining neural function.”

Phase 1 Trial: Safety Confirmed, Therapeutic Potential Emerges

The recently completed Phase 1 trial focused on evaluating safety and pharmacokinetics in healthy participants. According to Dr. Chruscinski, “Lucid-MS was safe and well-tolerated, with no adverse events. We’re also pleased with the drug levels observed in blood, which we believe are therapeutic.”

This milestone is crucial for advancing to Phase 2, where the company will begin testing Lucid-MS in MS patients to assess efficacy.

What to Expect in Phase 2

The company is actively designing its Phase 2 trial with a projected start in Q1 2026, pending FDA clearance via an Investigational New Drug (IND) application in late 2025.

Key details under consideration:

  • The trial will include roughly 60 MS patients (30 receiving Lucid-MS and 30 on placebo).

  • Outcomes will be measured using MRI scans and clinical assessments to evaluate both biological and functional improvement.

  • While the exact location is yet to be confirmed, Quantum is exploring options to include Canadian sites in recognition of the drug’s Canadian origins.

Support From the Scientific Community

Feedback from global experts at major MS conferences in North America and Europe has been overwhelmingly positive. “The response has been tremendous,” said Dr. Chruscinski. “There’s a real appetite for a drug that targets neurodegeneration, which remains an unmet need in MS.”

This third-party validation underscores the broader scientific and commercial relevance of Quantum BioPharma’s work.

A Human-Centered Mission With Investor Appeal

Dr. Chruscinski also emphasized his personal motivation. “It’s exciting to be part of something that could make a real difference. I was there when the first dose was administered in our Phase 1 trial. That’s a moment I won’t forget.”

While the drug development process remains long and complex, Quantum BioPharma has achieved a significant milestone that positions the company—and Lucid-MS—at the forefront of innovation in MS treatment.

For investors, the opportunity lies in Quantum’s unique approach, successful early data, and a clearly defined path toward a potential market-shifting solution.

Conclusion: A Meaningful Milestone With a Promising Horizon

With a Phase 1 trial successfully completed and a novel therapeutic mechanism unlike anything currently on the market, Quantum BioPharma is emerging as a company to watch in the fight against multiple sclerosis. As it gears up for its Phase 2 trial and FDA engagement, the company stands at a pivotal inflection point—one that could not only deliver long-term value for investors but also reshape the future of MS care.

To hear Dr. Chruscinski explain the science, milestones, and next steps in his own words, watch the full interview here: 

Canadian Small Cap Quantum BioPharma on The Verge of Multiple Sclerosis Breakthrough

Posted by Brittany McNabb at 5:01 PM on Tuesday, March 25th, 2025

KEY MILESTONES AND WHAT’S NEXT

  • Successful Phase 1 Trial: Lucid-MS has shown excellent safety with no serious side effects, paving the way for a groundbreaking treatment for MS.
  • Next Major Step: The Phase 2 trial is set for early 2026, with 60 participants.
  • FDA Submission on the Horizon: Plans to submit application to the FDA by late 2025, taking a huge step toward regulatory approval.
  • Massive Market Opportunity: With 2.9 million people worldwide affected by Multiple Sclerosis and the market projected to surpass $30 billion by 2030, Lucid-MS could potentially capture a significant share of this rapidly expanding space.

A NEW ERA IN MULTIPLE SCLEROSIS TREATMENT

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Lucid-MS is setting the stage to revolutionize MS treatment. Unlike existing therapies that only target immune system responses, Lucid-MS focuses on protecting and repairing myelin, the critical layer around nerve fibers. This novel approach has the potential to slow or even reverse disease progression—offering new hope for millions of MS sufferers.

HOW DOES IT WORK? A TOTALLY NEW APPROACH TO TREATING MS

Think of nerves like electrical wires in your body, and myelin as the protective coating around those wires. With Multiple Sclerosis, the immune system attacks this coating (called demyelination), causing damage that leads to muscle weakness, vision problems, and difficulty moving.

Most MS treatments try to calm the immune system to slow down the attack. Lucid-MS is different. Instead of focusing on the immune system, it works directly on the myelin to stabilize and protect it from damage.

WHY IS THIS IMPORTANT?

By keeping myelin intact, Lucid-MS may help slow down the progression of MS and prevent disability—something current MS drugs don’t do very well.

SCIENTIFIC BREAKTHROUGH BACKED BY INDUSTRY RECOGNITION

Lucid-MS is backed by cutting-edge research from Dr. Lakshmi Khotra’s lab at the University of Toronto, where the critical process of myelin breakdown in MS patients was discovered. The drug’s ability to address this underlying issue is a potential game-changer in neurodegenerative treatments.

It’s already gaining enthusiastic support from leading medical experts and researchers, underscoring its transformative potential.

A VISION FOR THE FUTURE

Dr. Andrzej Chruscinski, Vice President of Scientific and Clinical Affairs at Quantum BioPharma, expressed the company’s excitement about Lucid-MS’s future.

“We are on the cusp of something monumental. Lucid-MS has the potential to transform MS treatment and open doors for treating other nerve-related diseases. As we move toward Phase 2 and beyond, we’re excited to bring this innovative therapy to the patients who need it most.”

With promising clinical results, a massive market opportunity, and rising industry recognition, Quantum BioPharma is leading the charge in next-generation treatments for Multiple Sclerosis 

YOUR NEXT $QNTM STEPS

$QNTM HUB On AGORACOM: https://agoracom.com/ir/Quantumbiopharma $QNTM 5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/Quantumbiopha… $QNTM Official Verified Discussion Forum On AGORACOM: https://agoracom.com/ir/Quantumbiopha… Connect With AGORACOM Anyway You Like AGORACOM Website: https://www.agoracom.com – The Most Trusted Source Of Small Cap Information AGORACOM YouTube: Hit That Subscribe Button Right Now For More Powerful Videos AGORACOM X: https://www.x.com/AGORACOM Verified Top 0.2% Account AGORACOM Spotify: https://open.spotify.com/show/74mVPkf… Planes, Trains, Automobiles & Walking The Dog AGORACOM

Mining Legend Ewan Downie Leverages His Network & Success To Launch Giant Venture Capital

Posted by Brittany McNabb at 11:52 AM on Monday, January 27th, 2025

Ewan Downie’s career in the mining industry spans over 25 years, marked by remarkable success in company-building, major discoveries, and accretive acquisitions. As the former CEO of i-80 Gold Corp, President and CEO of Premier Gold Mines, and CEO of Wolfden Resources Corporation, Downie led these companies through transformative stages, culminating in high-value takeover transactions. Notably, he orchestrated the acquisition of the Hardrock gold project from Barrick Gold for just $3 million, a move that would later become the flagship asset for Equinox Gold.

In addition to his leadership roles, Downie was awarded the 2003 Bill Dennis Prospector of The Year by the PDAC for his major polymetallic base metal discovery in Canada, further cementing his reputation as one of the industry’s foremost visionaries.

TRANSITIONING TO VENTURE CAPITAL: GIANT VENTURE CAPITAL’S AMBITIOUS STRATEGY

Now, as the Principal at Giant Venture Capital, Downie is channeling his expertise into high-growth exploration opportunities. In this exclusive interview with AGORACOM Founder George Tsiolis, Downie shares how his extensive mining experience and success in acquisitions are informing his new venture, which aims to identify and develop undervalued grassroots projects with massive upside potential. Downie reveals that his team is already working on projects with mining giants like Glencore and is exploring new opportunities in Nevada and other high-potential jurisdictions.

STRATEGIC VISION FOR THE FUTURE OF EXPLORATION AND MINING CAPITAL

Giant Venture Capital’s strategy is simple but powerful: identify and develop undervalued, advanced grassroots projects with a clear path to commercialization. Downie’s team plans to launch one new company per year, with a strong focus on leveraging technological advances, including AI-driven exploration, to accelerate discovery and improve efficiency in the field.

ADDRESSING CHALLENGES IN CANADIAN MINING AND LOOKING AHEAD

During the conversation, Downie also discusses the challenges currently facing the Canadian mining sector, from regulatory hurdles to strained relations with First Nation communities. He advocates for a more business-friendly approach to permitting, which could unlock faster approvals and drive industry growth. Despite the sector’s cyclical challenges, Downie remains optimistic about the future of exploration and the potential for venture capital to play a transformative role.

THE ROAD AHEAD: A BRIGHT FUTURE FOR MINING EXPLORATION

Downie’s transition to venture capital is backed by his deep understanding of the mining sector, a proven ability to identify value, and a strategic vision that incorporates the latest technological advancements. As he continues to build Giant Venture Capital, he remains committed to discovering the next big mining opportunity—and investors with an eye on high-growth, long-term potential should keep a close watch on this evolving story.

Quantum BioPharma Sues CIBC, RBC & Others For $700 Million Alleging Spoofing/Short Selling Stock Manipulation

Posted by Brittany McNabb at 3:18 PM on Monday, November 18th, 2024

Quantum BioPharma (Formerly FSD Pharma) has filed a groundbreaking $700 million lawsuit against major Canadian banks, CIBC and RBC, alleging a scheme of stock price manipulation known as “spoofing.” CEO and Co-Chairman Zeeshan Saeed explains that this isn’t just a shot in the dark—industry experts estimate that damages could exceed $1 billion for $QNTM. 

The company’s legal team, confident in the strength of the case, has agreed to take it on a contingency basis, signaling their belief that this could be a watershed moment for both Quantum BioPharma and the entire small cap sector.

“Our goal is to seek justice for our shareholders and stop manipulative practices that hurt ordinary investors,” Saeed stated, underscoring the severity of the issue.

SPOOFING: A MARKET MANIPULATION TACTIC WITH HIGH STAKES

The crux of the lawsuit revolves around a deceptive trading tactic known as spoofing, where large orders are placed and then canceled to manipulate stock prices. According to Zeeshan, this method has been used by CIBC and other financial institutions to artificially drive down Quantum BioPharma’s share price, resulting in significant losses. This isn’t an isolated issue—similar market manipulation has been flagged by advocacy groups like Save Canadian Mining.

The case has been filed in the U.S. District Court for the Southern District of New York, a jurisdiction known for its expertise in financial offenses. Zeeshan emphasized the importance of this venue, noting that “the judges understand the nuances of these complex financial crimes.”

FIGHTING FOR SHAREHOLDERS

Beyond the financial toll, the impact on shareholder confidence has been severe. Zeeshan spoke candidly about the personal toll this manipulation has taken, including threats to his safety. Yet, he remains steadfast in his commitment to Quantum BioPharma’s future, outlining a strategy that could see the company investing in its pipeline and potentially issuing dividends to shareholders if the lawsuit is successful.

George and Zeeshan both drew comparisons to landmark legal battles like the Erin Brockovich case, illustrating how a small player can take on corporate giants and make a real difference.

If you enjoy David vs Goliath stories, watch or listen to this interview to see how this could transform Quantum BioPharma’s future and potentially end market manipulation in the small cap sector once and for all.

Kidoz Generates $USD 1.79 Million In Q1 24 Revenue, Record Revenue Expected In ’24

Posted by Brittany McNabb at 4:44 PM on Thursday, May 30th, 2024

If you believe in the future of digital advertising and you should because 50% of TV advertising has shifted to digital and continues to accelerate, then you are going to love discovering Kidoz who is the absolute leader in child safe mobile advertising.   

Offering a secure platform for brands to engage with their target audience. This innovative approach has not only propelled Kidoz to the forefront of the adtech industry but has also revolutionized how brands connect with younger demographics in a safe and meaningful way.

Just How BIG Are We Talking?

Kidoz powers nearly 5,000 apps worldwide, reaching over 400 MILLION kids, teens, and families monthly.

Working With Top Brands

  • Disney
  • McDonald’s
  • Hasbro
  • Lego
  • Trusted Partner of Apple & Google

In the realm of mobile AdTech, Kidoz Inc. shines in Q1-2024. Despite market challenges, Q1 2024 revenues hit USD $1.79 million and recorded revenues of $13,326,824 in 2023

Financial Performance and Efficiency Improvements

Financially, Kidoz has shown phenomenal growth, with revenues rising from $1.9 million in 2017 to $13.3 million in 2023.

In Q1-2024, Kidoz saw a 7% revenue increase to nearly $1.8 million vs. Q1-23 revenue: $1.67M and a 43% rise in gross profit due to reduced operating expenses.

Significant cost efficiency was achieved in media costs, leading to improved profitability despite Q1 being the slowest quarter of the year.

Competitive Advantages in Mobile Gaming

Kidoz capitalizes on the shift from traditional TV to digital, specifically targeting kids on mobile games.

The platform provides interactive advertising opportunities, where users engage directly with ads, unlike passive viewing on YouTube.

With changes in tech privacy and cookie usage, Kidoz cookie-less, context-based approach offers a robust alternative, making it a strong competitor in the mobile gaming ad space.

Strategic Staffing and Partnerships

Kidoz expanded its workforce and forged seven new sales partnerships globally in 2023, aiming to enhance its market reach and operational capacity.

Comments From the CEO 

“We’re proud of the revenue growth and financial improvements achieved in Q1 2024″, stated Jason Williams, Kidoz CEO.  “The digital advertising landscape continues to evolve in 2024 with a transition from the heightened activity seen during the pandemic.  However, Kidoz has adapted its strategy and been successful refining our strategies to meet the changing market dynamics,” continued Williams.

Kidoz’s stellar Q1 2024 revenue and 2023 performance confirms its leadership in child-safe mobile advertising. Watch this compelling interview with Jason Williams, Kidoz Inc CEO. 

Lancaster Resources Believes They Are On The Cusp of A Groundbreaking Lithium Find

Posted by Brittany McNabb at 5:10 PM on Tuesday, May 7th, 2024

If you need reasons to believe in the future of electric vehicles and and the role lithium is going to play in this massive paradigm shift, then consider the following:

  1. The automotive industry is expected to invest $500 BILLION in the transition to EVs by 2030.
  2. 20M EV Vehicle sales projected by ‘25
  3. The Tesla Model S Long Range is reported to contain ~350 kilograms of lithium per vehicle

Enter Lancaster Resources, a dynamic exploration company dedicated to this emerging energy sector transition. Through the development of Net Zero Lithium, Lancaster will help power the future of Carbon free lithium development and production.

Major Lithium Breakthrough
Lancaster is on the verge of a groundbreaking discovery in lithium exploration, particularly at the Alkali Flat Project in New Mexico. With exclusive acquisition rights covering 5,200 acres, this property boasts exceptional accessibility with its proximity to both an interstate highway and a railway.

Striking Parallels
The Alkali Flat Project bears remarkable resemblance to Clayton Valley, the only active lithium mine in the US, projecting production of 10,000 tonnes of lithium carbonate-equivalent annually.

Cutting-edge AI / Drone Technology
Through a strategic alliance with KorrAI Technologies, Lancaster leverages cutting-edge imaging technology to expedite exploration processes, promising faster and more precise results. This partnership underscores Lancaster’s commitment to sustainable resource development and positions them as trailblazers in the industry.

Insights from Penny White
CEO Penny White sheds light on the meticulous research behind Lancaster’s lithium ventures, showcasing years of groundwork and strategic planning. The recent finding of unusual conductivity in underground water suggests there could be large amounts of lithium hidden underground. This discovery matches what’s expected in Clayton Valley, where there’s a high potential for finding significant lithium deposits. Expectations soar as Lancaster gears up for its maiden drill program, poised to validate the lithium concentrations in aquifers and potentially delineate a valuable resource.

Anticipated negotiations for off-take agreements signal promising prospects amidst the global deficit of lithium, driven not only by EV adoption but also by the expanding requirements of the AI and sustainable energy sectors.

Quote from Andrew Watson, Lancaster’s VP Engineering & Operations
“The approval of our maiden drilling application is confirmation of our commitment to responsible, minimal impact exploration and the last major hurdle before launching our maiden drilling program at Alkali Flat.”
With the recent approval of the Drill Permit for the Alkali Flat Lithium Brine Project, Lancaster Resources marks a pivotal milestone in its journey towards responsible and impactful exploration. As Lancaster progresses towards drilling the first well at Alkali Flat, witness the unfolding of a potentially game-changing discovery in the world of lithium exploration.

Discover the untapped potential of Lancaster Resources Inc. Watch the full interview now and explore the future of lithium innovation. Visit AGORACOM to access exclusive insights and stay ahead of the curve in the small cap market.

Kidoz Generates $USD 13.3M In Revenue For ’23, Record Revenue Expected In ’24

Posted by Brittany McNabb at 10:23 AM on Tuesday, April 30th, 2024

If you believe in the future of digital advertising – and you should because 50% of TV advertising has shifted to digital and continues to accelerate – then Kidoz (KIDZ: TSXV) is worth discovering.

Why? Because Kidoz is the absolute leader in child-safe mobile advertising reaching millions of kids, teens, and families each month.

Just How BIG Are We Talking?

Kidoz powers nearly 5,000 apps worldwide, reaching over 400 MILLION kids, teens, and families monthly.

Working With Top Brands

  • Disney
  • McDonald’s
  • Hasbro
  • Lego
  • Trusted Partner of Apple & Google

In the realm of mobile AdTech, Kidoz Inc. shines with its 2023 financial report. Despite market challenges, 2023 annual revenues hit USD $13.3 million.

Highlights include: 

  • Total Revenue: Kidoz recorded revenues of $13,326,824 in 2023
  • Programmatic Revenue Surge: A standout achievement in 2023 was the 239% increase in programmatic ad revenue, highlighting a shift towards more dynamic, automated ad placements.
  • Investment in R&D and Marketing: The company boosted its R&D and marketing spend, preparing for future growth and diversification into new demographic segments including teens and families.
  • Strategic Staffing and Partnerships: Kidoz expanded its workforce and forged seven new sales partnerships globally, aiming to enhance its market reach and operational capacity.

“Historically, large, kids-focused brands reached consumers through traditional media channels utilizing television, radio, and print to communicate their messages. In the rapidly evolving landscape of digital advertising, Kidoz is at the forefront of transforming how major brands connect with their youngest audiences by enabling their message to reach their audience, contextually and safely via mobile digital devices.” Jason Williams, Kidoz CEO.

Kidoz’s stellar 2023 performance confirms its leadership in child-safe mobile advertising. Watch this compelling interview with Jason Williams, Kidoz Inc CEO.

Lancaster Resources To Deploy AI To Find Gold Near The Largest Gold Mine In Saskatchewan

Posted by Brittany McNabb at 10:20 AM on Tuesday, April 30th, 2024

With the price of gold hovering over $2,300 and near all-time highs, as well as, surging prices in copper and other metals, investors are looking for great undiscovered resource companies that are now starting to emerge into the spotlight.

Lancaster Resources (LCR: CSE) (LANRF: OTCQB) is primarily engaged in exploring lithium and uranium and other critical minerals, with a goal to produce Net-Zero Lithium. Guiding Lancaster is CEO Penny White and skilled management and technical teams with collective involvement in over 15 commercial mineral discoveries, so it should come as no surprise the team is expanding its portfolio to include some very interesting opportunities in gold.

40 KILOMETRES FROM LARGEST GOLD MINE IN THE PROVINCE

Lancaster announced its latest endeavour: the acquisition of the Piney Lake Gold Property. Nestled in Saskatchewan, Canada, this 2,267.8-hectare property represents an exciting addition to Lancaster’s exploration portfolio.

Situated just 65 kilometers east of La Ronge Provincial Park, Piney Lake is surrounded by established gold claims.

Specifically, Saskatchewan’s largest gold mine, SSR Minerals Seabee Operations, is located approximately 40 km to the north Piney Lake, with the Santoy underground mine in continuous commercial production since 2014.  Commercial production at the Seabee underground mine commenced in 1991 and exhausted Mineral Resources in 2018.

Moving beyond gold, North Arrow Minerals’ discovery of diamonds in 2013, followed by Alto Minerals’ exploration in 2014, emphasizes the properties’ mineralization and exploration upside for gold, copper, and other minerals.

Its accessibility via provincial highways adds to its appeal as a prospective exploration site.

HISTORY INDICATES HIGH-GRADE GOLD POTENTIAL

Historical samplings have identified significant gold showings along a north-south trend, indicating the property’s high-grade potential. These findings, coupled with modern exploration techniques, set the stage for exciting discoveries.

DRONES, ARTIFICIAL INTELLIGENCE AND HIGH TECH EXPLORATION

Lancaster intends to deploy hyperspectral imaging, which combines satellite imagery and drone surveys. The company will then leverage artificial intelligence and machine learning to delineate a focused field exploration program.

Penny White, President and CEO of Lancaster Resources Inc.

“The acquisition of the Piney Lake Gold Property marks an exciting addition to our exploration portfolio.”

CONCLUSION:

The acquisition of Piney Lake Gold Property signifies a significant step forward for Lancaster Resources and great diversification of the Company’s strong portfolio of critical minerals projects.

Watch this exclusive interview with Lancaster Resources’ CEO, Penny White, as she discusses the strategic significance of the Piney Lake acquisition.

Green River Gold Begins Gold Mining In May As Gold Flirts With $2,300

Posted by Brittany McNabb at 12:06 PM on Friday, April 5th, 2024

If you hit .300 in baseball, you’re a Hall Of Famer

If you shot 50% in basketball, you’re an icon

If you go 50-50 in drilling, you’re Green River Gold

In the dynamic realm of small-cap resources, Green River Gold emerges as a player, offering investors a unique blend of opportunities in both the resilient gold market and the burgeoning battery metals sector. With Gold standing strong as it approaches $2,300 and the electric vehicle revolution igniting unprecedented demand for critical minerals, Green River Gold’s strategic projects in British Columbia position it at the forefront of a transformative era in the resource industry.

GEARING UP FOR PLACER GOLD MINING

The company is gearing up to initiate placer gold mining on their Wabi claims along the Swift River. This marks a significant milestone in their quest for self-sustaining cash flow while advancing exploration ventures simultaneously.

The company staked its claim on six contiguous placer mining territories along the Swift River, rich in history dating back to the Cariboo Gold Rush in the 1870s. With strategic foresight, the Company capitalizes on the region’s potential, aligning its operations with surging gold prices.

COMMENTS FROM GREEN RIVER GOLD CEO PERRY LITTLE 

“With gold prices at current levels, we see the possibility of creating significant cash flow from our placer mining assets. It is our goal to create sufficient revenue from operations to eventually cover at least our annual operating costs so that any money we raise in the capital markets goes directly to exploration or acquisitions. Our primary focus remains the Quesnel Nickel Project and our other mineral properties. In the meantime, any mining activity that produces cash flow for the Company benefits all our shareholders.”

6000 Meters of Drilling at the Quesnel Nickel Project

The company recently secured a drilling permit for their Quesnel Nickel Project, with plans for an extensive 6000-meter drilling campaign. With the green light on a five-year area-based exploration permit, the Company sets the stage for intensive exploration efforts.

Twenty holes, each spanning 300 meters, are earmarked for 2024, promising to unearth invaluable insights into the project. Additionally, a robust ~4,000-tonne bulk sampling program gained approval.

Watch this powerful interview with Perry Little, Green River Gold President and CEO.